NXS next science limited

Ann: Investor Presentation - Q4 FY21, page-6

  1. 169 Posts.
    lightbulb Created with Sketch. 163
    I don't understand why they just gave away Xperience to Zimmer. I don't see terms either.

    This company is proving that it can't execute as of yet. Disappointing that they still had to run a study, which they did not foresee - nor announce well. As far as I can see there is no clear strategy in place to seize the target segment, and all I see is free shares being paid out and a CR coming up within the year.

    How is it possible to get zero transparency on:
    1. The marketing strategy and its financial ramifications
    2. The rationale, timelines, and benefits of studies and
    3. Business update...

    There are so many questions around revenue generation - is it bulk sale, is it even getting any traction, what is the rationale behind getting sales team and now partnering.

    I'm interested in the company but why are there so many question marks on the most basic business activity and capabilities... I can only conclude by all metric.. so far.. that we have an incompetent group of executives.. that or does anyone have any insights to point to me to the right direction?

    The product seems great, but is it just me that can't figure out what is going on?

    happy to hear if anyone has any insights...
    Last edited by CrispyPork777: 04/02/22
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.0¢
Change
0.005(3.70%)
Mkt cap ! $40.96M
Open High Low Value Volume
13.5¢ 14.0¢ 13.5¢ $2.18K 15.92K

Buyers (Bids)

No. Vol. Price($)
8 2242641 13.5¢
 

Sellers (Offers)

Price($) Vol. No.
14.0¢ 642631 11
View Market Depth
Last trade - 16.10pm 18/07/2025 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.